Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
Clinical trial NCT03859128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03859128
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-05
- Primary completion
- 2026-12-31
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.